Starpharma Holdings Ltd (SPL) - Total Liabilities

Latest as of June 2026: AU$5.24 Million AUD ≈ $3.71 Million USD

Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has total liabilities worth AU$5.24 Million AUD (≈ $3.71 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SPL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Starpharma Holdings Ltd - Total Liabilities Trend (2000–2026)

This chart illustrates how Starpharma Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SPL asset base.

Starpharma Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of Starpharma Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Leonteq AG SW:LEON	Switzerland	CHF10.47 Billion
Aurion Resources Ltd V:AU	Canada	CA$5.95 Million
Xperi Corp NYSE:XPER	USA	$536.31 Million
Boryszew SA WAR:BRS	Poland	zł2.21 Billion
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd. SHE:301063	China	CN¥1.09 Billion
COG Financial Services Ltd AU:COG	Australia	AU$536.47 Million
TSC Auto ID Technology Co Ltd TWO:3611	Taiwan	NT$7.28 Billion
i3 Verticals Inc NASDAQ:IIIV	USA	$226.65 Million

Liability Composition Analysis (2000–2026)

This chart breaks down Starpharma Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SPL equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Starpharma Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Starpharma Holdings Ltd (2000–2026)

The table below shows the annual total liabilities of Starpharma Holdings Ltd from 2000 to 2026.

Year	Total Liabilities	Change
2026-06-30	AU$5.24 Million ≈ $3.71 Million	-18.40%
2025-06-30	AU$6.42 Million ≈ $4.54 Million	-26.16%
2024-06-30	AU$8.70 Million ≈ $6.15 Million	-49.64%
2023-06-30	AU$17.27 Million ≈ $12.22 Million	-2.87%
2022-06-30	AU$17.78 Million ≈ $12.58 Million	+62.57%
2021-06-30	AU$10.94 Million ≈ $7.74 Million	+41.10%
2020-06-30	AU$7.75 Million ≈ $5.49 Million	+19.93%
2019-06-30	AU$6.46 Million ≈ $4.57 Million	+23.50%
2018-06-30	AU$5.23 Million ≈ $3.70 Million	-6.65%
2017-06-30	AU$5.61 Million ≈ $3.97 Million	-41.68%
2016-06-30	AU$9.62 Million ≈ $6.80 Million	+40.88%
2015-06-30	AU$6.83 Million ≈ $4.83 Million	+74.51%
2014-06-30	AU$3.91 Million ≈ $2.77 Million	+51.47%
2013-06-30	AU$2.58 Million ≈ $1.83 Million	-54.03%
2012-06-30	AU$5.62 Million ≈ $3.97 Million	+165.70%
2011-06-30	AU$2.11 Million ≈ $1.50 Million	-22.37%
2010-06-30	AU$2.72 Million ≈ $1.93 Million	-18.67%
2009-06-30	AU$3.35 Million ≈ $2.37 Million	-21.59%
2008-06-30	AU$4.27 Million ≈ $3.02 Million	-9.14%
2007-06-30	AU$4.70 Million ≈ $3.33 Million	+27.11%
2006-06-30	AU$3.70 Million ≈ $2.62 Million	+45.91%
2005-06-30	AU$2.53 Million ≈ $1.79 Million	+182.02%
2004-06-30	AU$898.45K ≈ $635.71K	-38.98%
2003-06-30	AU$1.47 Million ≈ $1.04 Million	-7.58%
2002-06-30	AU$1.59 Million ≈ $1.13 Million	+43.55%
2001-06-30	AU$1.11 Million ≈ $785.26K	+456.90%
2000-06-30	AU$199.28K ≈ $141.00K	--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$273.41 Million

AU$386.41 Million AUD

Market Cap Rank

#15400 Global

#411 in Australia

Share Price

AU$0.81

Change (1 day)

+1.89%

52-Week Range

AU$0.22 - AU$0.81

All Time High

AU$2.49